The Rebecca and John Moores Cancer Center is the region's only

NCI-designated Cancer Center NCI-designated Cancer Centers are a group of 73 cancer research institutions in the United States supported by the National Cancer Institute. Three designations are recognized: ''Comprehensive Cancer Centers'', ''Clinical Cancer Centers'' and ''B ...

, part of UC San Diego Health and affiliated with the

University of California, San Diego The University of California, San Diego (UC San Diego in communications material, formerly and colloquially UCSD) is a public university, public Land-grant university, land-grant research university in San Diego, California, United States. Es ...

. It is supported, in part, by the

National Cancer Institute The National Cancer Institute (NCI) coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH), which is one of eleven agencies that are part of the U.S. Department of Health and Human Services. ...

History

The center was established in 1978 and received its NCI designation the same year. It earned comprehensive status in 2001. There are approximately 360 faculty members affiliated with the center. A five-story building, home to the center, was opened in La Jolla in 2005. The Moores Cancer Center provides outpatient treatment on site. Inpatient hospital treatment is provided at the adjacent Jacobs Medical Center in the Pauline and Stanley Foster Pavilion for Cancer Care, which opened in 2016 and has three floors dedicated to oncology, and at UC San Diego Medical Center in Hillcrest, which has recently expanded its cancer services. Scott Lippman served as the director from 2012 until 2021. He previously worked at MD Anderson Cancer Center. Lippman was succeeded by Joseph Califano who served in the role from 2022 until early 2023. The six major research programs at Moores Cancer Center comprise the following: Cancer Biology; Cancer Genes and Genome; Cancer Prevention and Control; Hematologic Malignancies; Reducing Cancer Disparities; and Tumor Growth, Invasion, and Metastasis.Center for Personalized Cancer Therapy
/ref>

Notable faculty

* Roger Tsien * Thomas Kipps, discoverer of ROR1, and contributed to the development of cirmtuzumab * Don W. Cleveland * Marilyn Farquhar * Napoleone Ferrara * Quyen T. Nguyen

References

{{authority control UC San Diego Health Teaching hospitals in California Hospitals established in 1978